Product Pathways
BCP0165 AEG3482
Inhibitor of JNK signalling.
BCP0194 VX950(Telaprevir)
Telaprevir (VX-950) is an HCV NS3-4A serine protease inhibitor with IC50 of 0.35 μM.
BCP0284 VX-222
VX-222 (HCV Infection) is a small molecule non-nucleoside inhibitor of HCV NS5B polymerase that is being investigated for the treatment of hepatitis C virus infection.
BCP0358 Daclatasvir(BMS790052)
Daclatasvir (BMS-790052) is a first-in-class, highly-selective oral HCV NS5A inhibitor.
BCP000597 VCH-759
VCH759, VCH-759 is a novel, orally bioavailable non-nucleoside hepatitis C virus RNA-dependent RNA polymerase inhibitor.
BCP000717 Danoprevir(ITMN-191)
Danoprevir is a highly potent, orally absorbed inhibitor of the NS3/4A protease for treating chronic HCV infections.
BCP000830 Boceprevir
BCP001213 Ribavirine
BCP001650 PSI6206
PSI-6206 is a selective inhibitor of hepatitis C virus (HCV).
BCP0006751 TCS JNK 5a
Selective inhibitor of JNK2 and JNK3 (pIC50 values are 6.7, 6.5, <5.0 and <4.8 for JNK3, JNK2, JNK1 and p38α respectively).
第一页 1 2 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.